← Evidence map

ReviewDrugs2018

Tafenoquine: First Global Approval.

James E FramptonPubMed ↗Publisher ↗

No numbers read from the abstract.

33 papers cite it

2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it

The trial

NCT05203744phase 4200 enrolled2022
Full record →Abstract, authors, funding and every citing paper · PMID 30229442